| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 7e-06 |